enVVeno Medical Corp reports results for the quarter ended June 30 - Earnings Summary
enVVeno Medical Corp reports results for the quarter ended June 30 - Earnings Summary
enVVeno Medical Corp NVNO.OQ reported a quarterly adjusted loss of $5.37 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-11.55. The lone analyst forecast for the quarter was for a loss of $4.69 per share.
Reported revenue was zero; analysts expected zero.
The company reported a quarterly loss of $3.6 million.
enVVeno Medical Corp shares had fallen by 0.8% this quarter and lost 5.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 48.5% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
Wall Street's median 12-month price target for enVVeno Medical Corp is $30.00, about 64.6% above its last closing price of $10.63
This summary was machine generated from LSEG data July 31 at 07:51 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -4.69 | -5.37 | Missed |
Mar. 31 2026 | -8.40 | ||
Sep. 30 2025 | -10.50 | -8.05 | Beat |